2025 Year-End Patient Centricity Review

Progress and Perspectives in Patient Centricity: 2025 Reflections

Patient centricity is a movement now. At Cactus Life Sciences, we don’t just follow the trend; we help set it. Here’s how your voices, our actions, and the industry’s bold steps made 2025 a landmark year...
Read More

Top Stories

Patient Centricity

The Evolution of Patient Centricity in Pharma

Patient centricity: A defining imperative in healthcare As...
AI in Scientific Publications

The Role of AI in Transforming Scientific

Scientific publishing is evolving rapidly with the advent of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...

Launch Excellence: The Path Forward for Medical Affairs

Learn how Medical Affairs can redefine launch excellence by streamlining the journey from clinical trial...
HEOR Pharma Payers

Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements

HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
Medical Device Regulation

Clinical Evidence: How Much Is Enough?

Ensuring the safety and functionality of your medical device is vital. But how much clinical...
Health Literacy

Health Literacy – Cactus Life Sciences Leads the Way

It’s our responsibility as an industry to emphasize the importance of health literacy and help...
Medication without Harm

World Patient Safety Day 2022 – Medication Without Harm

Medication use around the world has increased in the last few years; a 2019 CDC...
Image - Effectiveness of Artificial Intelligence–Powered Translation Tools in Developing Medical Publications An Assessment of Japanese-to-English Translation

Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation

Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical...

Learn more ABOUT our company.